These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 17325657)
1. Could Ca2+ sensitizers rescue patients from chronic congestive heart failure? Endoh M Br J Pharmacol; 2007 Apr; 150(7):826-8. PubMed ID: 17325657 [TBL] [Abstract][Full Text] [Related]
2. [Levosimendan--an alternative to conventional inotropic treatment of patients with acute heart failure?]. Rasmussen T; Schmidt H Ugeskr Laeger; 2006 Jan; 168(3):261-5. PubMed ID: 16430807 [TBL] [Abstract][Full Text] [Related]
3. Pharmacology of SCH00013: a novel Ca2+ sensitizer. Endoh M; Sugawara H; Mineshima M Cardiovasc Drug Rev; 2001; 19(4):345-66. PubMed ID: 11830752 [TBL] [Abstract][Full Text] [Related]
4. What is the in vivo mechanism of action of levosimendan? MacGowan GA J Card Fail; 2005 Aug; 11(6):482; author reply 482-3. PubMed ID: 16105641 [No Abstract] [Full Text] [Related]
5. A Review on Role of the Calcium Sensitive Inotropic Agent, Levosimendan and Its Metabolites. Asif M Mini Rev Med Chem; 2018; 18(16):1354-1362. PubMed ID: 27594341 [TBL] [Abstract][Full Text] [Related]
6. The role of Ca++-sensitizers for the treatment of heart failure. Lehmann A; Boldt J; Kirchner J Curr Opin Crit Care; 2003 Oct; 9(5):337-44. PubMed ID: 14508145 [TBL] [Abstract][Full Text] [Related]
10. [Calcium sensitizers--a new group of drugs that increase myocardium contractility]. Laine M; Lehtonen L; Nieminen MS Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622 [No Abstract] [Full Text] [Related]
15. Medical support and surgery of the failing heart: levosimendan. Toller W; Knez I Scand J Surg; 2007; 96(2):121-4. PubMed ID: 17679353 [No Abstract] [Full Text] [Related]
16. Will calcium sensitizers play a role in the treatment of heart failure? Nielsen-Kudsk JE; Aldershvile J J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S77-84. PubMed ID: 8907135 [TBL] [Abstract][Full Text] [Related]
17. [Levosimendan: a new option in the pharmacologic management of cardiac insufficiency]. Del-Razo OE; Carballal-Sanjurjo JC; Campos Lara MG; Palma-Aguirre JA Gac Med Mex; 2003; 139(1):87-9. PubMed ID: 12666417 [TBL] [Abstract][Full Text] [Related]
18. [Levosimendan for treatment of heart failure]. Yasumura Y Nihon Rinsho; 2007 May; 65 Suppl 5():169-72. PubMed ID: 17571380 [No Abstract] [Full Text] [Related]
19. Levosimendan: a new option in acute cardiac failure. Holley AD; Ziegenfuss M Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641 [No Abstract] [Full Text] [Related]
20. Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure. Berger R; Moertl D; Huelsmann M; Bojic A; Ahmadi R; Heissenberger I; Pacher R Eur J Heart Fail; 2007 Feb; 9(2):202-8. PubMed ID: 16859992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]